STERIS plc (NYSE:STE) Shares Sold by Fiduciary Trust Co

Fiduciary Trust Co trimmed its holdings in STERIS plc (NYSE:STE) by 10.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 2,837 shares of the medical equipment provider’s stock after selling 339 shares during the period. Fiduciary Trust Co’s holdings in STERIS were worth $583,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Avalon Trust Co acquired a new stake in STERIS in the 4th quarter worth about $30,000. Human Investing LLC acquired a new position in shares of STERIS in the 4th quarter valued at about $31,000. Anfield Capital Management LLC lifted its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares in the last quarter. Manchester Capital Management LLC lifted its stake in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. Finally, Brown Brothers Harriman & Co. lifted its stake in shares of STERIS by 66.7% in the 4th quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 88 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Performance

Shares of NYSE:STE opened at $226.54 on Monday. The company has a market cap of $22.26 billion, a P/E ratio of 48.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a one year low of $200.98 and a one year high of $248.24. The business’s 50-day simple moving average is $223.40 and its 200 day simple moving average is $218.80.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 annualized dividend and a yield of 1.01%. STERIS’s dividend payout ratio is presently 48.41%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Piper Sandler lifted their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Monday, April 7th. Stephens upgraded STERIS to a “strong-buy” rating in a report on Thursday, May 1st. Finally, JMP Securities reiterated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.